STOCKS TELEGRAPH

Tag: PDSB

  • Why PDS Biotechnology Corporation (PDSB) stock lost its positivity in Monday’s after-market?

    Why PDS Biotechnology Corporation (PDSB) stock lost its positivity in Monday’s after-market?

    PDS Biotechnology Corporation (PDSB) shares declined 19.05% in after-market on Monday, June 14, 2021, and closed that day at $10.41 per share. Earlier, PDSB’s stock gained 6.63% in normal Monday’s trading session. PDSB shares have risen 916.60% over the last 12 months, and they have moved up by 36.81% in the past week. Over the past three months, the stock has gained 135.53%, while over the past six months, it has added 489.91%.

    Let’s discuss its recent developments briefly

    The proposed offering of Common Stock

    On June 14, 2021, PDS Biotechnology Corporation commenced an underwritten public offering of shares of its common stock. All of the shares of common stock to be sold in the offering will be offered by PDS Biotech.

    Underwriters will get a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering.

    Oncology Research and Development Day

    PDS Biotechnology Corporation will host an Oncology R&D Day for analysts, investors, and the scientific community on Wednesday, June 16, 2021.

    Oncology R&D Day will focus on the Company’s advancements in its ongoing preclinical and clinical work and will feature presentations from:

    • Frank Bedu-Addo, President and CEO, PDS Biotech
    • Lauren V. Wood, Chief Medical Officer, PDS Biotech
    • Jeffrey Schlom, Chief of the Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institute of Health
    • Julius Strauss, Principal Investigator, Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institute of Health
    • Caroline Jochems, Staff Scientist, Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institute of Health

    Presentation of Interim Data for PDS0101 in NCI-Led Phase 2 Clinical Study 

    On June 08, 2021, PDS Biotechnology Corporation presented the interim data for PDS0101from the Phase 2 trial led by the National Cancer Institute (NCI), of the National Institutes of Health (NIH), at the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting.

    Data from a total of 25 patients were available as of the time of presentation submission in which, 100% (25/25) of patients enrolled had failed chemotherapy treatment.

    96% (24/25) of patients enrolled had failed both chemotherapy and radiation treatment and 56% (14/25) of patients enrolled had failed checkpoint inhibitor therapy (checkpoint inhibitor refractory).

    Joining Russell Microcap® Index

    On June 07, 2021 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation announced that the company is set to join the Russell Microcap® Index after the 2021 Russell indexes annual reconstitution, effective after the US market opens on June 28, 2021.

    Partnership with Head and Neck Cancer Alliance (HNCA)

    On May 27, 2021, PDS Biotechnology announced a partnership with the Head and Neck Cancer Alliance (HNCA). This collaboration will raise awareness of new and developing treatment options, including available clinical trials, for patients with HPV-attributed head and neck cancer diagnoses.

    Conclusion

    The proposed offer of its common stock could be the reason behind its gain or loss on Monday as there is no other recent news. We have to wait and see how PDSB performs on Tuesday.

  • Pre-Market Cues: 29 Stocks Roaring for Change On December 7th

    Pre-Market Cues: 29 Stocks Roaring for Change On December 7th

    HL Acquisitions Corp. (HCCH) is up more than 5.38% at $25.25 in pre-market hours Monday December 07, 2020. The firm recently reported that that the shareholders of HL have approved the business combination between HL and Fusion Fuel at an annual general meeting of shareholders. The stock had jumped over 27.65% to $23.96 in the last trading session.
    China HGS Real Estate Inc. (NASDAQ: HGSH) shares are trading down -17.83% at $2.12 at the time of writing. Company’s 52-week ranged between $0.48 to $4.40.
    Cinedigm Corp. (CIDM) grew over 4.07% at $0.7269 in pre-market trading today after announcing eight additional linear streaming channels are now available on Rad’s fast-growing global streaming platform.
    Before the trading started on December 07, 2020, PDS Biotechnology Corporation (PDSB) is down -7.49% to reach $2.47. It has been trading in a 52-week range of $0.62 to $4.98.
    Pioneer Power Solutions Inc. (PPSI), a Electrical Equipment & Parts company, dropped about -6.59% at $4.11 in pre-market trading Monday. The company lately declared that it has finalized a conclusive settlement with Myers Power Products, Inc., a specialty electrical products manufacturer.
    Castor Maritime Inc. (NASDAQ: CTRM) shares are trading down -3.25% at $0.1935 at the time of writing. Company’s 52-week ranged between $0.11 to $2.60.
    RMG Acquisition Corp. (RMG) is down more than -5.62% at $17.31 in pre-market hours Monday December 07, 2020. The firm recently announced the nomination of Paul Williams to serve on the board of directors of Romeo Power upon consummation of merger. The stock had jumped over 19.95% to $18.34 in the last trading session.
    Before the trading started on December 07, 2020, Energy Fuels Inc. (UUUU) is up 6.2% to reach $2.74. It has been trading in a 52-week range of $0.78 to $2.42.
    Safe-T Group Ltd (SFET) stock soared 20.49% to $1.47 in the pre-market trading. The technology firm recently declared that it will hold a virtual event – webinar with Fujitsu, a global information and communication technology (ICT) company, on December 10, 2020.
    Before the trading started on December 07, 2020, ENGlobal Corporation (ENG) is up 4.42% to reach $1.89. It has been trading in a 52-week range of $0.46 to $4.32.
    Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) shares are trading down -6.96% at $1.47 at the time of writing after reporting that it will provide its QuadSight® multispectral vision solution, and is expected to receive approximately one million USD from the European Commission through the Horizon 2020 framework program. Company’s 52-week ranged between $0.46 to $1.95. Analysts have a consensus price target of $16.
    Hennessy Capital Acquisition Corp. IV (HCAC) is up more than 16.13% at $15.62 in pre-market hours Monday December 07, 2020. The stock had jumped over 10.52% to $13.45 in the last trading session.
    Sesen Bio Inc. (SESN) is up more than 4.58% at $1.6 in pre-market hours Monday December 07, 2020. The firm recently revealed partnership with Hikma Pharmaceuticals for the commercialization of Vicineum™ in the Middle East and North Africa. The stock had jumped over 15.04% to $1.53 in the last trading session.
    Before the trading started on December 07, 2020, Apache Corporation (APA) is down -2.5% to reach $14.8. It has been trading in a 52-week range of $3.80 to $33.77.
    BlackBerry Limited (NYSE: BB) shares are trading down -2.7% at $8.29 at the time of writing after declaring that it will report results for the third quarter of fiscal year 2021 at 5:30 p.m. ET on Thursday, December 17, 2020. Company’s 52-week ranged between $2.70 to $9.69.
    TechnipFMC plc (NYSE: FTI) shares are trading down -3.41% at $9.92 at the time of writing. Company’s 52-week ranged between $4.49 to $21.84.
    Nesco Holdings Inc. (NSCO) tumbled over -12.41% at $5.86 in pre-market trading today as the firm revealed that it has entered into a definitive agreement to acquire Custom Truck One Source (“CTOS”) for a purchase price of $1.475 billion.
    Penn Virginia Corporation (PVAC) is down more than -2.05% at $9.55 in pre-market hours Monday December 07, 2020. The stock had jumped over 7.50% to $9.75 in the last trading session.
    Uranium Energy Corp. (UEC) stock soared 11.57% to $1.35 in the pre-market trading after reporting that the U.S. Senate Committee on Environment and Public Works (EPW) has approved a bipartisan bill entitled the American Nuclear Infrastructure Act (ANIA). The most recent rating by Canaccord Genuity, on October 14, 2020, is a Speculative buy.
    Lyft Inc. (NASDAQ: LYFT) shares are trading up 2.67% at $47.33 at the time of writing. Company’s 52-week ranged between $14.56 to $54.50.
    Verb Technology Company Inc. (VERB) grew over 2.46% at $1.25 in pre-market trading today. The firm lately revealed that it will deliver a presentation at the Benzinga Global Small Cap Conference being held December 8-9, 2020.
    TransEnterix Inc. (TRXC) is down more than -7.22% at $0.47 in pre-market hours Monday December 07, 2020. The stock had jumped over 6.63% to $0.51 in the last trading session.
    FuelCell Energy Inc. (FCEL), a Electrical Equipment & Parts company, rose about 3.77% at $8.25 in pre-market trading Monday following the closing of public offering of 39,696,320 shares of common stock.
    Before the trading started on December 07, 2020, Senseonics Holdings Inc. (SENS) is up 9.28% to reach $0.4699. It has been trading in a 52-week range of $0.35 to $1.78.
    Before the trading started on December 07, 2020, The Macerich Company (MAC) is down -2.44% to reach $11.6 after declaring that the Company has earned Bureau Veritas SafeGuard™ Hygiene Excellence and Safety Certification for key properties. It has been trading in a 52-week range of $4.56 to $26.20.
    Southwestern Energy Company (SWN) stock plunged -2.33% to $2.93 in the pre-market trading. The most recent rating by UBS, on December 01, 2020, is a Sell.
    Gamida Cell Ltd. (GMDA) is up more than 7.6% at $7.5 in pre-market hours Monday December 07, 2020 after reporting in an oral presentation the updated and expanded results from a Phase 1 clinical study of GDA-201. The stock had jumped over 5.61% to $6.97 in the last trading session.
    Sintx Technologies Inc. (NASDAQ: SINT) shares are trading up 2.45% at $2.09 at the time of writing. Company’s 52-week ranged between $0.28 to $3.30.
    Matinas BioPharma Holdings Inc. (MTNB) grew over 12.84% at $1.23 in pre-market trading today after announcing collaboration with the National Institute of Allergy and Infectious Diseases to evaluate oral formulations of Gilead’s antiviral remdesivir utilizing Matinas’ LNC Platform delivery technology.